Relevant bibliographies by topics / Lymphoma Non-Hodgkin

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Lymphoma Non-Hodgkin'

Author: Grafiati
Published: 4 June 2021
Last updated: 11 March 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Lymphoma Non-Hodgkin.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Lymphoma Non-Hodgkin"

1

Leventhal, Brigid G., and Gregory J. Kato. "Childhood Hodgkin and Non-Hodgkin Lymphomas." Pediatrics In Review 12, no. 6 (1990): 171–79. http://dx.doi.org/10.1542/pir.12.6.171.

Full text
Abstract:
Lymphomas were recognized originally by Virchow as swellings of lymph nodes that were unrelated to tuberculosis or to other recognized pathology in the drainage area of the lymph node group. Lymphomas were not recognized initially as malignancies; proof of this came only in this century. Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL), which together account for approximately 12% of childhood cancer, have become among the most curable of pediatric malignancies. Today, the projected cure rates for children in certain categories are as high as 90%. Recent advances in molecular biology have
APA, Harvard, Vancouver, ISO, and other styles
2

Hartmann, Sylvia, Sonja Scharf, Yvonne Steiner, et al. "Landscape of 4D Cell Interaction in Hodgkin and Non-Hodgkin Lymphomas." Cancers 13, no. 20 (2021): 5208. http://dx.doi.org/10.3390/cancers13205208.

Full text
Abstract:
Profound knowledge exists about the clinical, morphologic, genomic, and transcriptomic characteristics of most lymphoma entities. However, information is currently lacking on the dynamic behavior of malignant lymphomas. This pilot study aimed to gain insight into the motility of malignant lymphomas and bystander cells in 20 human lymph nodes. Generally, B cells were faster under reactive conditions compared with B cells in malignant lymphomas. In contrast, PD1-positive T cells did not show systematic differences in velocity between reactive and neoplastic conditions in general. However, lympho
APA, Harvard, Vancouver, ISO, and other styles
3

Merryman, Reid W., Philippe Armand, Kyle T. Wright, and Scott J. Rodig. "Checkpoint blockade in Hodgkin and non-Hodgkin lymphoma." Blood Advances 1, no. 26 (2017): 2643–54. http://dx.doi.org/10.1182/bloodadvances.2017012534.

Full text
Abstract:
AbstractClassical Hodgkin lymphoma (cHL) is characterized by nearly universal genetic alterations in 9p24.1, resulting in constitutive expression of PD-1 ligands. This likely underlies the unique sensitivity of cHL to PD-1 blockade, with response rates of ∼70% in relapsed/refractory disease. There are now numerous clinical trials testing PD-1 inhibitors in earlier stages of treatment and in combination with many other therapies. In general, non-Hodgkin lymphomas (NHLs) do not display a high frequency of 9p24.1 alterations and do not share cHL’s vulnerability to PD-1 blockade. However, a few en
APA, Harvard, Vancouver, ISO, and other styles
4

Chen, Ling, Yaling Yang, C. Cameron Yin, et al. "Aberrant Expression of Golgin-84 in Non-Hodgkin Lymphomas and Plasma Cell Myeloma." Blood 118, no. 21 (2011): 4633. http://dx.doi.org/10.1182/blood.v118.21.4633.4633.

Full text
Abstract:
Abstract Abstract 4633 Background: Golgins are proteins of the Golgi complex. Several Golgins have been implicated in apoptosis. Expression of Golgin-84, a Golgin protein, is altered in apoptotic WEHI-231, a B-cell lymphoma line, suggesting that Golgin-84 may play a role in lymphoid tumorigenesis. Here, we aimed to determine the expression levels of Golgin-84 in human primary non-Hodgkin lymphomas and plasma cell myeloma. Design: Golgin-84 expression was investigated in non-Hodgkin lymphoma cell lines by using Western blot analysis and polyclonal antibodies. Using immunohistochemical stains, W
APA, Harvard, Vancouver, ISO, and other styles
5

Ahn, Ji Yong. "Gastrointestinal Tract Lymphoma." Korean Journal of Helicobacter and Upper Gastrointestinal Research 22, no. 1 (2022): 18–28. http://dx.doi.org/10.7704/kjhugr.2021.0064.

Full text
Abstract:
The gastrointestinal tract is the most common site of extranodal lymphoma, and more than 95% of gastrointestinal lymphoma cases are of the non-Hodgkin type. The stomach is the primary site of extranodal non-Hodgkin lymphoma, and more than 98% of primary gastric lymphoma (PGL) cases are diffuse large B-cell lymphomas (DLBCL) and mucosa-associated lymphoid tissue (MALT) lymphomas. Because PGL usually presents with nonspecific clinical symptoms and various endoscopic features, its diagnosis is mainly dependent on histopathologic findings. Chemotherapy is the first-line treatment choice for gastri
APA, Harvard, Vancouver, ISO, and other styles
6

Northend, Michael, and Jonathan Lambert. "Non-Hodgkin lymphoma." Medicine 49, no. 5 (2021): 293–300. http://dx.doi.org/10.1016/j.mpmed.2021.02.007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Ninkovic, Slavisa, and Jonathan Lambert. "Non-Hodgkin lymphoma." Medicine 45, no. 5 (2017): 297–304. http://dx.doi.org/10.1016/j.mpmed.2017.02.008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Shankland, Kate R., James O. Armitage, and Barry W. Hancock. "Non-Hodgkin lymphoma." Lancet 380, no. 9844 (2012): 848–57. http://dx.doi.org/10.1016/s0140-6736(12)60605-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Jacobson, Caron A. "Non-Hodgkin Lymphoma." Hematology/Oncology Clinics of North America 33, no. 4 (2019): i. http://dx.doi.org/10.1016/s0889-8588(19)30068-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Evans, Linda S., and Barry W. Hancock. "Non-Hodgkin lymphoma." Lancet 362, no. 9378 (2003): 139–46. http://dx.doi.org/10.1016/s0140-6736(03)13868-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Dissertations / Theses on the topic "Lymphoma Non-Hodgkin"

1

Busson, Raphaël. "Fatigue chronique chez les survivants d'un lymphome." Thesis, Normandie, 2018. http://www.theses.fr/2018NORMC238/document.

Full text
Abstract:
La progression des traitements dans le lymphome amène à s’intéresser à la qualité de vie des survivants. La fatigue chronique est le problème le plus fréquemment décrit par les survivant. Dans le cadre du lymphome hodgkinien, le niveau de fatigue revêt une importance particulière par les patients ont entre 20 et 40 ans et sont confronté aux problématiques de retour à l’emploi. Dans la première partie de cette thèse, nous traiterons des causes de la fatigue et de sont évolutions pour les lymphomes hodgkinien et les lymphomes non-hodgkinien. En particulier, nous mettrons en lumière l’impacte des
APA, Harvard, Vancouver, ISO, and other styles
2

Amini, Rose-Marie. "Hodgkin Lymphoma : Studies of Advanced Stages, Relapses and the Relation to Non-Hodgkin Lymphomas." Doctoral thesis, Uppsala : Acta Universitatis Upsaliensis : Univ.-bibl. [distributör], 2002. http://publications.uu.se/theses/91-554-5265-5/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Bley, Linda D. "Nutritional factors and non-Hodgkin's Lymphoma /." Thesis, Connect to this title online; UW restricted, 1996. http://hdl.handle.net/1773/10864.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Holmes, Matthew. "Oncolytic virotherapy for the treatment of Non-Hodgkin Lymphoma." Thesis, University of Leeds, 2018. http://etheses.whiterose.ac.uk/22218/.

Full text
Abstract:
Non-Hodgkin Lymphoma (NHL) is a diverse group of more than 80 predominantly B cell cancers of the lymphatic system. Poor survival rates in aggressive subsets, the transformation of indolent subsets into aggressive forms, and the emergence of therapy-resistance warrants research into novel therapies. Oncolytic viruses (OV) preferentially replicate in and kill malignant cells. Here we investigate the efficacy of two OV, reovirus Type 3 Dearing and Coxsackievirus Type A21 (CVA21), against NHL cell lines and primary patient samples, examine the role of the tumour microenvironment in virus suscepti
APA, Harvard, Vancouver, ISO, and other styles
5

Patience, Lauren Alexandra. "Apoptosis-driven microenvironmental conditioning by microvesicles in non-Hodgkin lymphoma." Thesis, University of Edinburgh, 2017. http://hdl.handle.net/1842/28710.

Full text
Abstract:
Plasma membrane derived microvesicles (MV) are nanoscale particles released from cells both constitutively and in response to stimuli including stress, apoptosis and oncogenic transformation. Due to their mechanism of biogenesis, the majority of MV expose phosphatidylserine (PS) on their surface and as such can be identified by staining with annexin V (AxV). First observed nearly 40 years ago as coagulant ‘dust’ originating from activated platelets, MV were initially studied for their role in thrombosis. In more recent years it has become apparent that MV release is increased in several diseas
APA, Harvard, Vancouver, ISO, and other styles
6

Gisbertz, I. A. M. "Non-Hodgkin's lymphoma of the gastro-intestinal tract clinicopathological correlations /." Maastricht : Maastricht : UPM, Universitaire Pers Maastricht ; University Library, Maastricht University [Host], 1998. http://arno.unimaas.nl/show.cgi?fid=8423.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Ziepert, Marita. "Prognosemodelle für chemotherapieinduzierte hämatologische Nebenwirkungen bei Patienten mit aggressiven Non-Hodgkin-Lymphomen." Doctoral thesis, Universitätsbibliothek Leipzig, 2010. http://nbn-resolving.de/urn:nbn:de:bsz:15-qucosa-62960.

Full text
Abstract:
Derzeit ist es gängige Praxis, die Chemotherapie entsprechend der Körperoberfläche des Patienten zu dosieren. Diese Praxis ist jedoch nicht ideal, da es Patienten gibt, die starke Nebenwirkungen haben und andere, die kaum Nebenwirkungen aufweisen. Damit intelligentere Dosierungsschemata entwickelt werden können und prophylaktische Maßnahmen zum Verhindern von Therapienebenwirkungen besser geplant werden können, ist die Kenntnis der Faktoren erforderlich, welche die Nebenwirkungen verursachen. Die hämatologischen Nebenwirkungen der Chemotherapie sind dabei am stärksten ausgeprägt und führen oft
APA, Harvard, Vancouver, ISO, and other styles
8

Nakatani, Koya. "Roles and Limitations of FDG PET in Pediatric Non-Hodgkin Lymphoma." Kyoto University, 2012. http://hdl.handle.net/2433/157424.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Müller, Anja. "Multiple outcomes for PI3K/Akt/mTOR targeting in non-Hodgkin lymphoma." Doctoral thesis, Humboldt-Universität zu Berlin, Lebenswissenschaftliche Fakultät, 2015. http://dx.doi.org/10.18452/17284.

Full text
Abstract:
Wachstumsfaktor bedingte Aktivierung des PI3K/Akt/mTOR Signalweg wirkt positiv auf Vermehrung und Überleben. Konstitutive Aktivierung des Signalweges in NHL ist jedoch an Tumorprogression und Therapieresistenz beteiligt. Am Zelllinienmodell wurden zwei mögliche Therapiestrategien der PI3K/Akt/mTOR Inhibition erprobt, PI3K Inhibition mit BKM120 und horizontale Kombination von Zytostatika mit PI3K/Akt/mTOR Inhibitoren Erstens, BKM120 hat Antitumoraktivität in NHL und induziert Zelltod. Auf molekularer Ebene führt BKM120 vermittelte Dephosphorylierung von CDK1 an Y15 zur Aktivierung des M-Phase
APA, Harvard, Vancouver, ISO, and other styles
10

Aggarwal, Mohit. "Biological pathways in B-cell non-Hodgkin's lymphoma." Stockholm : Department of Medicine, Karolinska Institutet, 2009. http://diss.kib.ki.se/2009/978-91-7409-739-9/.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Lymphoma Non-Hodgkin"

1

1946-, Armitage James O., ed. Non-Hodgkin lymphomas. 2nd ed. Lippincott Williams & Wilkins, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

1946-, Armitage James O., ed. Non-Hodgkin lymphomas. 2nd ed. Lippincott Williams & Wilkins, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

1946-, Armitage James O., ed. Non-Hodgkin lymphomas. 2nd ed. Lippincott Williams & Wilkins, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Quesenberry, Peter J., and Jorge J. Castillo, eds. Non-Hodgkin Lymphoma. Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-5851-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Evens, Andrew M., and Kristie A. Blum, eds. Non-Hodgkin Lymphoma. Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-13150-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

M, Mauch Peter, ed. Non-Hodgkin's lymphomas. Lippincott Williams & Wilkins, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Low-grade non-Hodgkin lymphoma. 6th ed. Lymphoma Association, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Agrawal, Archi, Venkatesh Rangarajan, and Ameya D. Puranik, eds. PET/CT in Non-Hodgkin Lymphoma. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-79007-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Productions, Jack Digital, and Princess Margaret Hospital, eds. Understanding non-hodgkin's lymphoma. Jack Digital Productions, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Histopathology of non-Hodgkin Lymphomas: (based on the updated Kiel classification). 2nd ed. Springer-Verlag, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Lymphoma Non-Hodgkin"

1

Kirsch, Brian James, Shu-Jyuan Chang, Michael James Betenbaugh, and Anne Le. "Non-Hodgkin Lymphoma Metabolism." In The Heterogeneity of Cancer Metabolism. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-65768-0_7.

Full text
Abstract:
AbstractNon-Hodgkin lymphomas (NHLs) are a heterogeneous group of lymphoid neoplasms with different biological characteristics. About 90% of all lymphomas in the United States originate from B lymphocytes, while the remaining originate from T cells [1]. The treatment of NHLs depends on the neoplastic histology and stage of the tumor, which will indicate whether radiotherapy, chemotherapy, or a combination is the best suitable treatment [2]. The American Cancer Society describes the staging of lymphoma as follows: Stage I is lymphoma in a single node or area. Stage II is when that lymphoma has spread to another node or organ tissue. Stage III is when it has spread to lymph nodes on two sides of the diaphragm. Stage IV is when cancer has significantly spread to organs outside the lymph system. Radiation therapy is the traditional therapeutic route for localized follicular and mucosa-associated lymphomas. Chemotherapy is utilized for the treatment of large-cell lymphomas and high-grade lymphomas [2]. However, the treatment of indolent lymphomas remains problematic as the patients often have metastasis, for which no standard approach exists [2].
APA, Harvard, Vancouver, ISO, and other styles
2

Chan, Ka Wah, Demetrios Petropoulos, Eric L. Chang, and Michael E. Rytting. "Hodgkin Lymphoma and Non-Hodgkin Lymphoma." In Pediatric Oncology. Springer US, 2005. http://dx.doi.org/10.1007/978-0-387-24472-3_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Chen, Andy I. "Hodgkin Lymphoma and Non-Hodgkin Lymphoma." In Blood and Marrow Transplant Handbook. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-53626-8_17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Chiu, Brian C. H., and Ningqi Hou. "Epidemiology and Etiology of Non-Hodgkin Lymphoma." In Non-Hodgkin Lymphoma. Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-13150-4_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Maddocks, Kami, and Kristie A. Blum. "Treatment Strategies in Mantle Cell Lymphoma." In Non-Hodgkin Lymphoma. Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-13150-4_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Kubuschok, Boris, Gerhard Held, and Michael Pfreundschuh. "Management of Diffuse Large B-Cell Lymphoma (DLBCL)." In Non-Hodgkin Lymphoma. Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-13150-4_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Gooptu, M., R. Rhoades, and B. Pro. "Current Management of Peripheral T-Cell Lymphomas." In Non-Hodgkin Lymphoma. Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-13150-4_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Singavi, Arun K., Alexandra M. Harrington, and Timothy S. Fenske. "Post-transplant Lymphoproliferative Disorders." In Non-Hodgkin Lymphoma. Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-13150-4_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Aldoss, Ibrahim, and Auayporn Nademanee. "Allogeneic Hematopoietic Cell Transplantation in Non-Hodgkin’s Lymphomas." In Non-Hodgkin Lymphoma. Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-13150-4_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Ondrejka, Sarah L., and Eric D. Hsi. "Pathology of B-Cell Lymphomas: Diagnosis and Biomarker Discovery." In Non-Hodgkin Lymphoma. Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-13150-4_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Lymphoma Non-Hodgkin"

1

de Melo-Filho, Fernando, Renato Ricci, Maick Neves, Telmo Belsuzarri, Mateus Deltreggia, and João Mattos. "Non-Hodgkin Lymphoma Mimicking Chronic Subdural Hematoma: Case Report." In XXXII Congresso Brasileiro de Neurocirurgia. Thieme Revinter Publicações Ltda, 2018. http://dx.doi.org/10.1055/s-0038-1672805.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Caliari, Vitória de Ataide, Herika Negri, Claudio vidal, Bruno lobo, Dhyego lacerda, and Débora de Moura Muniz. "Primary Central Nervous System Lymphoma of the Posterior Fossa in Immunocompetent Patient: A Case Report and Review of Literature." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.025.

Full text
Abstract:
Context: Primary central nervous system lymphomas (PCNSL) are a rare but very aggressive subtype of extranodal non-Hodgkin lymphomas. They represent only 4% of primary central nervous system lesions and are more common in patients with aggressive non-Hodgkin lymphomas, who are HIV positive. Moreover, PCNSL, usually presents as intraparenchymal supratentorial expansive lesions, while secondary CNS lymphomas tend to present as metastases in the leptomeninges. Although they are more common in immunocompromised patients, their incidence has increased with advancing age. Due to its uniqueness in fi
APA, Harvard, Vancouver, ISO, and other styles
3

Latour, Simon, Isabelle Mahouche, Floriane Cherrier, Jean-Philippe Merlio, Sandrine Poglio, and Laurence Bresson Bepoldin. "Abstract 1881: STIM1 and Orai1 control non-Hodgkin lymphoma cells migration." In Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-1881.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Pahwa, D., F. Ugbode, and A. Mattoo. "Mistaken Identity: Non-resolving Pneumonia as a Presentation of Hodgkin Lymphoma." In American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2369.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Nordon, E. Karoubi, E. Palazzo, SA Rouidi, and O. Meyer. "AB0157 Paraneoplasic hypercalcemia complicating a b cell non-hodgkin lymphoma (nhl)." In Annual European Congress of Rheumatology, Annals of the rheumatic diseases ARD July 2001. BMJ Publishing Group Ltd and European League Against Rheumatism, 2001. http://dx.doi.org/10.1136/annrheumdis-2001.479.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Wang, Jun, Joanne S. Colt, Peter S. Thorne, et al. "Abstract 5736: Household endotoxin levels and risk of non-Hodgkin lymphoma." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-5736.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Kamada, Natalie, Robert Oda, Tiffany Shieh, et al. "Abstract A04: Unique Raman spectroscopic fingerprints of Burkitt non-Hodgkin lymphoma." In Abstracts: AACR Special Conference: Pediatric Cancer Research: From Basic Science to the Clinic; December 3-6, 2017; Atlanta, Georgia. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.pedca17-a04.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Granada, Mark, and Arthur C. Theodore. "A Case Of Bronchocentric Granulomatosis Following Treatment For Non Hodgkin Lymphoma." In American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans. American Thoracic Society, 2010. http://dx.doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a4505.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Cerhan, James R., Helen M. O'Connor, Zachary S. Fredericksen, et al. "Abstract 2811: Vitamin K intake and risk of non-Hodgkin lymphoma (NHL)." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-2811.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Bilić, Ernest, Zrinko Šalek, Matej Jelić, et al. "295 Non-Hodgkin Lymphoma in children: single center experience during 20 years." In 10th Europaediatrics Congress, Zagreb, Croatia, 7–9 October 2021. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2021. http://dx.doi.org/10.1136/archdischild-2021-europaediatrics.295.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Lymphoma Non-Hodgkin"

1

Wang, Jinjin. Efficacy and safety of copanlisib in relapse/refractory B-cell non-Hodgkin lymphoma: A meta-analysis of prospective clinical trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.10.0008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Mao, Qiyuan, Lanchun Liu, Xueqian Wang, et al. Compound Kushen injection combined with chemotherapy for patients with non-Hodgkin lymphoma: A protocol for systematic review and meta-analysis of randomized controlled trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.2.0063.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography